Cancer Prevention Pharmaceuticals, Inc. (CPP), a private clinical stage biotech company developing novel therapeutics to prevent cancer and other diseases, announced today the appointment of Willene Brondum as its new Associate Vice President of Regulatory Affairs and Quality Assurance. Ms. Brondum will lead all of CPP’s regulatory and quality assurance operations for its advancing pipeline … Continue reading Cancer Prevention Pharmaceuticals Appoints New AVP of Regulatory Affairs and Quality Assurance